Disclosures for "Application of a Clinical Algorithm on Real-World Electronic Medical Record Data to Assist With Earlier Detection of Amyotrophic Lateral Sclerosis"
-
Dr. Fiander has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharmaceuticals. Dr. Fiander has received research support from Mitsubishi Tanabe Pharmaceuticals.
-
Dr. Ghavanini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitisubishi Tanabe Pharm.
-
Mr. Pham has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma Canada.
-
Pinay Kainth has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma Canada. Pinay Kainth has received personal compensation for serving as an employee of Ultragenyx Canada.
-
Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for pepgen. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa.